Wood JPM - Search Results

1

Retinal energy metabolism in health and glaucoma.

Casson RJ, Chidlow G, Crowston JG, Williams PA, Wood JPM. Casson RJ, et al. Among authors: wood jpm. Prog Retin Eye Res. 2021 Mar;81:100881. doi: 10.1016/j.preteyeres.2020.100881. Epub 2020 Jul 23. Prog Retin Eye Res. 2021. PMID: 32712136 Review.

2

Ganglion cell death in glaucoma: what do we really know?

Osborne NN, Wood JP, Chidlow G, Bae JH, Melena J, Nash MS. Osborne NN, et al. Br J Ophthalmol. 1999 Aug;83(8):980-6. doi: 10.1136/bjo.83.8.980. Br J Ophthalmol. 1999. PMID: 10413706 Free PMC article. Review. No abstract available.

3

Neuroprotection in relation to retinal ischemia and relevance to glaucoma.

Osborne NN, Ugarte M, Chao M, Chidlow G, Bae JH, Wood JP, Nash MS. Osborne NN, et al. Surv Ophthalmol. 1999 Jun;43 Suppl 1:S102-28. doi: 10.1016/s0039-6257(99)00044-2. Surv Ophthalmol. 1999. PMID: 10416754 Review.

4

Topically applied betaxolol attenuates NMDA-induced toxicity to ganglion cells and the effects of ischaemia to the retina.

Osborne NN, DeSantis L, Bae JH, Ugarte M, Wood JP, Nash MS, Chidlow G. Osborne NN, et al. Exp Eye Res. 1999 Sep;69(3):331-42. doi: 10.1006/exer.1999.0706. Exp Eye Res. 1999. PMID: 10471341

5

The potential of neuroprotection in glaucoma treatment.

Osborne NN, Chidlow G, Nash MS, Wood JP. Osborne NN, et al. Curr Opin Ophthalmol. 1999 Apr;10(2):82-92. doi: 10.1097/00055735-199904000-00002. Curr Opin Ophthalmol. 1999. PMID: 10537768 Review.

6

An investigation into the potential mechanisms underlying the neuroprotective effect of clonidine in the retina.

Chao HM, Chidlow G, Melena J, Wood JP, Osborne NN. Chao HM, et al. Brain Res. 2000 Sep 15;877(1):47-57. doi: 10.1016/s0006-8993(00)02592-0. Brain Res. 2000. PMID: 10980242

7

5-Hydroxytryptamine1A agonists: potential use in glaucoma. Evidence from animal studies.

Osborne NN, Wood JP, Melena J, Chao HM, Nash MS, Bron AJ, Chidlow G. Osborne NN, et al. Eye (Lond). 2000 Jun;14 ( Pt 3B):454-63. doi: 10.1038/eye.2000.131. Eye (Lond). 2000. PMID: 11026974 Review.

8

A hypothesis to explain ganglion cell death caused by vascular insults at the optic nerve head: possible implication for the treatment of glaucoma.

Osborne NN, Melena J, Chidlow G, Wood JP. Osborne NN, et al. Br J Ophthalmol. 2001 Oct;85(10):1252-9. doi: 10.1136/bjo.85.10.1252. Br J Ophthalmol. 2001. PMID: 11567974 Free PMC article. Review. No abstract available.

9

Expectations in the treatment of retinal diseases: neuroprotection.

Osborne NN, Chidlow G, Wood JP, Schmidt KG, Casson R, Melena J. Osborne NN, et al. Curr Eye Res. 2001 May;22(5):321-32. doi: 10.1076/ceyr.22.5.321.5496. Curr Eye Res. 2001. PMID: 11605607 Review. No abstract available.

10

Topical flunarizine reduces IOP and protects the retina against ischemia-excitotoxicity.

Osborne NN, Wood JP, Cupido A, Melena J, Chidlow G. Osborne NN, et al. Invest Ophthalmol Vis Sci. 2002 May;43(5):1456-64. Invest Ophthalmol Vis Sci. 2002. PMID: 11980861

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

118 results

Search Page